# Member 3 Master Completion Audit

**Project**: SIH 2026 Problem Statement 26038 — Explainable AI for Diabetic Retinopathy Screening in Rural India  
**Team**: Team SweetSyntax  
**Author**: Member 3 — Dataset + Image Processing + Evaluation Lead  
**Branch**: `feature/member3-sprint4`  
**Base Commit**: `f5d2b27`  
**Main Branch Status**: Untouched (`cb8ed9a`)  

---

## Executive Audit Summary

This document provides a line-by-line audit of all Member 3 responsibilities defined in the **SIH PS26038 Technical Master Plan** and **Master Plan Part 2**. Each requirement is evaluated against the repository state and classified strictly into one of seven standardized status categories:

- **COMPLETE**: Implemented, demonstrable, empirically validated, documented, and integrated (or ready for integration).
- **PARTIALLY VALIDATED**: Implemented and algorithmically functional, but complete ground-truth quantitative validation is constrained by dataset/annotation availability.
- **NOT IMPLEMENTED**: Excluded from MVP scope per explicit Master Plan authorization (§6.3) due to lack of defensible ground truth/methods.
- **PENDING MEMBER 1**: Upstream Member 3 artifact ready; awaiting Member 1 UI/Dashboard integration.
- **PENDING MEMBER 2**: Evaluation framework ready; awaiting Member 2 final model weights.
- **BLOCKED BY DATA/TOOLING**: Requires unavailable ground truth annotations or specialized external toolchains.
- **DEPENDENT ON FINAL INTEGRATION**: Fully verified upstream; awaiting end-to-end system test.

---

## Comprehensive Responsibility Matrix

| # | Requirement | Master Plan Section | Primary Owner | Current Status | Verification Evidence / Location | Remaining Work | Dependency |
|---|---|---|---|---|---|---|---|
| 1 | Dataset Research & Isolation | §4, Part 2 §43 | Member 3 | **COMPLETE** | [verify_dataset_splits.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/verify_dataset_splits.py), `data/splits/test_split.csv` | None | Self-contained |
| 2 | Dataset Documentation | §4.1–4.3 | Member 3 | **COMPLETE** | [member3_sprint4_report.md](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/docs/research/member3_sprint4_report.md) | None | Self-contained |
| 3 | Role 2 Pipeline Infrastructure | §6.1–6.3 | Member 3 | **COMPLETE** | `modules/image_processing/code/verify_role2_components.m` | None | MATLAB Runtime |
| 4 | IQA Focus Check | §6.1 | Member 3 | **COMPLETE** | `check_image_quality.m`, [test_iqa_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_iqa_validation.py) | None | Self-contained |
| 5 | IQA Illumination Check | §6.1 | Member 3 | **COMPLETE** | `check_illumination.m`, [test_iqa_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_iqa_validation.py) | None | Self-contained |
| 6 | IQA FOV Boundary Estimation | §6.1 | Member 3 | **COMPLETE** | `check_fov.m`, [test_iqa_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_iqa_validation.py) | None | Self-contained |
| 7 | Fundus CLAHE Processing | §6.2 | Member 3 | **COMPLETE** | `preprocess_fundus.m`, [test_preprocessing_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_preprocessing_validation.py) | None | Self-contained |
| 8 | Illumination & Denoising | §6.2 | Member 3 | **COMPLETE** | `preprocess_fundus.m`, [test_preprocessing_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_preprocessing_validation.py) | None | Self-contained |
| 9 | Retinal Vessel Extraction | §6.3 | Member 3 | **COMPLETE** | `segment_vessels.m`, [test_morphology_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_morphology_validation.py) | None | Self-contained |
| 10 | Optic Disc Localization | §6.3 | Member 3 | **COMPLETE** | `detect_optic_disc.m`, [test_morphology_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_morphology_validation.py) | None | Self-contained |
| 11 | Fovea Localization | §6.3 | Member 3 | **COMPLETE** | `locate_fovea.m`, [test_morphology_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_morphology_validation.py) | None | Self-contained |
| 12 | Exudate Candidate Extraction | §6.3 | Member 3 | **PARTIALLY VALIDATED** | `detect_exudates.m`, `outputs/evaluation/idrid_segmentation_validation.json` | Requires supervised UNet segmentation | IDRiD Part A GT Masks |
| 13 | Microaneurysm Candidate Extraction | §6.3 | Member 3 | **PARTIALLY VALIDATED** | `detect_microaneurysms.m`, `outputs/evaluation/idrid_segmentation_validation.json` | Requires supervised UNet segmentation | IDRiD Part A GT Masks |
| 14 | Hemorrhage Candidate Extraction | §6.3 | Member 3 | **PARTIALLY VALIDATED** | `detect_hemorrhages.m`, `outputs/evaluation/idrid_segmentation_validation.json` | Requires supervised UNet segmentation | IDRiD Part A GT Masks |
| 15 | Neovascularization | §6.3 | Member 3 | **NOT IMPLEMENTED** | Documented limitation (Master Plan §6.3 MVP Scope Exclusion) | None (Excluded) | Excluded |
| 16 | Structured Retinal Features Interface | §6.4 | Member 3 | **COMPLETE** | `outputs/evaluation/structured_retinal_features_schema.json` | None | Member 1 Dashboard |
| 17 | Error Analysis | Part 2 §43 | Member 3 | **COMPLETE** | [member3_error_analysis.md](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/docs/research/member3_error_analysis.md) | None | Self-contained |
| 18 | Calibration Evaluation | §7.2 | Member 3 | **COMPLETE** | [test_calibration_validation.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_calibration_validation.py) | None | Self-contained |
| 19 | Messidor-2 External Validation | §8.1 | Member 3 | **COMPLETE** | `outputs/evaluation/external_validation/messidor_external_metrics.json` | None | Frozen Baseline |
| 20 | IDRiD Adaptation Experiment | §8.2 | Member 3 | **COMPLETE** | `outputs/evaluation/adaptation/adaptation_experiment_metrics.json` | None | Self-contained |
| 21 | Statistical Promotion/Rollback Decision | §8.3 | Member 3 | **COMPLETE** | `ROLLBACK` decision in [model_evidence_package.json](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/outputs/evaluation/model_evidence_package.json) | None | Self-contained |
| 22 | Model Evidence Package | §9.1 | Member 3 | **COMPLETE** | [model_evidence_package.json](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/outputs/evaluation/model_evidence_package.json), [test_sprint4_evidence_package.py](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/tests/test_sprint4_evidence_package.py) | None | Self-contained |
| 23 | Benchmark Comparison | §9.2 | Member 3 | **COMPLETE** | `outputs/evaluation/benchmark_comparison.csv` | None | Self-contained |
| 24 | Experiment Records & Provenance | §9.3 | Member 3 | **COMPLETE** | Provenance pointers in `model_evidence_package.json` | None | Self-contained |
| 25 | Simulink Parameter Handoff | §11.2 | Member 3 | **COMPLETE** | `docs/research/simulink_parameter_handoff.md` | None | Member 1/Simulink |
| 26 | Member 1 Integration Handoff | §12.1 | Member 3 | **COMPLETE** | [member3_member1_handoff.md](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/docs/research/member3_member1_handoff.md) | Awaiting Member 1 UI | Pending Member 1 |
| 27 | Member 2 Model Handoff Contract | §12.2 | Member 3 | **COMPLETE** | [member3_member2_handoff.md](file:///k:/SIH%202026/Diabetic%20Retinopathy/SIH-26038/docs/research/member3_member2_handoff.md) | Awaiting M2 candidate | Pending Member 2 |

---

## Key Findings & Verification Summary

1. **Dataset Strict Isolation**:
   - APTOS 2019: $N=439$ locked test split (zero leakage across 2051/440/439 splits).
   - IDRiD: $N=81$ (40 calibration-fit / 41 held-out validation, 0 overlap).
   - Messidor-2: $N=1,744$ frozen external dataset evaluation.
2. **IDRiD Adaptation Decision**:
   - **`ROLLBACK`** maintained. Specificity on held-out test set was $64.29\% < 85\%$ guardrail. Active baseline remains locked ResNet-50.
3. **Role 2 Pipeline Status**:
   - 8 VALIDATED components.
   - 3 PARTIALLY VALIDATED components (morphological lesion candidate extraction).
   - 1 NOT IMPLEMENTED component (Neovascularization excluded from MVP per §6.3).
